Health Ministry should put serious patients first

The Ministry of Health and Welfare canceled a public debate on expanding national health insurance coverage for hair loss treatment, a sign that the policy push has encountered resistance. The move appears to reflect growing criticism that limited health insurance funds, already facing deficit concerns, should not be used for hair loss treatment when patients with severe and rare diseases still struggle with treatment and drug costs.

The idea dates back to January 2022, when Lee Jae Myung, then a presidential candidate, made insurance coverage for hair loss treatment a campaign pledge. The debate resurfaced after President Lee, during a ministry briefing last December, described hair loss as a matter of survival rather than merely a cosmetic concern and ordered officials to review possible coverage. Health and Welfare Minister Jeong Eun-kyeong later said the ministry would pursue expanded coverage for hair loss treatment as a key task in the second half of this year. The ministry had completed a working-level review of coverage for hair loss medication, citing the need to reduce feelings of alienation among people aged 20 to 34, and planned to gather public opinion at a debate on July 4.

The reaction, however, was stronger than expected. While many men experiencing hair loss welcomed the proposal, opposition spread among women in their 20s and 30s, medical groups and patients with severe or rare diseases. The Korea Alliance of Patients Organization with Serious Diseases denounced the plan as “dangerous populism” that would shake the medical necessity and benefit priorities underpinning health insurance. The Korean Medical Association also warned that discussing coverage for hair loss treatment without a careful review of priorities and fiscal impact could distort the direction of health insurance financing.

The fundamental purpose of national health insurance is to protect lives and health from unexpected illness and the burden of costly medical care. Many seriously ill patients still cannot receive timely treatment because they lack money. Government policy should first focus on saving the lives of patients with life-threatening diseases. The cancellation of the debate should be an opportunity for the ministry to return to the starting point and reassess whether this policy is justified before moving further.